Skip to content

Clinical trials

Phase 3 Carcinoma trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 3 Country / region: Singapore Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20141
20161
20181
20192
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed4
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Exelixis2
Novartis Pharmaceuticals2
Abbott1
Ariad Pharmaceuticals1
Bayer1
Imunon1
Merck Sharp & Dohme LLC1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma13
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Adenocarcinoma3
Carcinoma, Hepatocellular3
Carcinoma, Renal Cell3
Neoplasm Metastasis3
Digestive System Diseases2
Digestive System Neoplasms2
Liver Diseases2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.